These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25894419)

  • 21. Sulfapyridine-like benzenesulfonamide derivatives as inhibitors of carbonic anhydrase isoenzymes I, II and VI.
    Alp C; Özsoy Ş; Alp NA; Erdem D; Gültekin MS; Küfrevioğlu Öİ; Şentürk M; Supuran CT
    J Enzyme Inhib Med Chem; 2012 Dec; 27(6):818-24. PubMed ID: 22188522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molten globule-like state of bovine carbonic anhydrase in the presence of acetonitrile.
    Safarian S; Saffarzadeh M; Zargar SJ; Moosavi-Movahedi AA
    J Biochem; 2006 Jun; 139(6):1025-33. PubMed ID: 16788053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diarylsulfonamides and their bioisosteres as dual inhibitors of alkaline phosphatase and carbonic anhydrase: Structure activity relationship and molecular modelling studies.
    Al-Rashida M; Ejaz SA; Ali S; Shaukat A; Hamayoun M; Ahmed M; Iqbal J
    Bioorg Med Chem; 2015 May; 23(10):2435-44. PubMed ID: 25865133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform.
    Maryanoff BE; McComsey DF; Costanzo MJ; Hochman C; Smith-Swintosky V; Shank RP
    J Med Chem; 2005 Mar; 48(6):1941-7. PubMed ID: 15771438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A QSAR study on relationship between structure of sulfonamides and their carbonic anhydrase inhibitory activity using the eigenvalue (EVA) method.
    Oltulu O; Yaşar MM; Eroğlu E
    Eur J Med Chem; 2009 Sep; 44(9):3439-44. PubMed ID: 19303173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety.
    Al-Said MS; Ghorab MM; Al-Dosari MS; Hamed MM
    Eur J Med Chem; 2011 Jan; 46(1):201-7. PubMed ID: 21112675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
    Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small-molecule suppression of misfolding of mutated human carbonic anhydrase II linked to marble brain disease.
    Almstedt K; Rafstedt T; Supuran CT; Carlsson U; Hammarström P
    Biochemistry; 2009 Jun; 48(23):5358-64. PubMed ID: 19415900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantum chemical QSAR models to distinguish between inhibitory activities of sulfonamides against human carbonic anhydrases I and II and bovine IV isozymes.
    Deeb O; Goodarzi M; Khadikar PV
    Chem Biol Drug Des; 2012 Apr; 79(4):514-22. PubMed ID: 22181786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-II.
    Banerjee AL; Swanson M; Roy BC; Jia X; Haldar MK; Mallik S; Srivastava DK
    J Am Chem Soc; 2004 Sep; 126(35):10875-83. PubMed ID: 15339172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.
    De Simone G; Di Fiore A; Menchise V; Pedone C; Antel J; Casini A; Scozzafava A; Wurl M; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2315-20. PubMed ID: 15837316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides.
    Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2007 Apr; 50(7):1651-7. PubMed ID: 17343373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents.
    Agrawal VK; Bano S; Supuran CT; Khadikar PV
    Eur J Med Chem; 2004 Jul; 39(7):593-600. PubMed ID: 15236839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase II-induced selection of inhibitors from a dynamic combinatorial library of Schiff's bases.
    Nasr G; Petit E; Supuran CT; Winum JY; Barboiu M
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6014-7. PubMed ID: 19796939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.
    Sethi KK; Verma SM; Prasanthi N; Sahoo SK; Parhi RN; Suresh P
    Bioorg Med Chem Lett; 2010 May; 20(10):3089-93. PubMed ID: 20443227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation of Phe91 to Asn in human carbonic anhydrase I unexpectedly enhanced both catalytic activity and affinity for sulfonamide inhibitors.
    Kockar F; Maresca A; Aydin M; Işik S; Turkoglu S; Sinan S; Arslan O; Güler OO; Turan Y; Supuran CT
    Bioorg Med Chem; 2010 Aug; 18(15):5498-503. PubMed ID: 20624682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: structure-based drug design, synthesis, and biological evaluation.
    Vernier W; Chong W; Rewolinski D; Greasley S; Pauly T; Shaw M; Dinh D; Ferre RA; Meador JW; Nukui S; Ornelas M; Paz RL; Reyner E
    Bioorg Med Chem; 2010 May; 18(9):3307-19. PubMed ID: 20363633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII.
    Sūdžius J; Baranauskienė L; Golovenko D; Matulienė J; Michailovienė V; Torresan J; Jachno J; Sukackaitė R; Manakova E; Gražulis S; Tumkevičius S; Matulis D
    Bioorg Med Chem; 2010 Nov; 18(21):7413-21. PubMed ID: 20889345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, in vitro antibacterial and carbonic anhydrase II inhibitory activities of N-acylsulfonamides using silica sulfuric acid as an efficient catalyst under both solvent-free and heterogeneous conditions.
    Massah AR; Adibi H; Khodarahmi R; Abiri R; Majnooni MB; Shahidi S; Asadi B; Mehrabi M; Zolfigol MA
    Bioorg Med Chem; 2008 May; 16(10):5465-72. PubMed ID: 18439830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements.
    Klinger AL; McComsey DF; Smith-Swintosky V; Shank RP; Maryanoff BE
    J Med Chem; 2006 Jun; 49(12):3496-500. PubMed ID: 16759092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.